Product Data Sheet

Dacomitinib impurity 3

Catalog No. A98656

main product photo
Dacomitinib impurity 3 is a known impurity associated with the tyrosine kinase inhibitor Dacomitinib. This compound can be utilized in analytical studies to evaluate the purity and stability of pharmaceutical formulations containing Dacomitinib. Its characterization is essential for ensuring the quality and compliance of drug products in the development process.
Chemical Information
Catalog NumA98656
M. Wt402.81
FormulaC19H16ClFN4O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2190490-31-2
Synonyms
SMILESO=C1N(C(CC1)O)C2=CC3=C(NC4=CC=C(C(Cl)=C4)F)N=CN=C3C=C2OC
Biological Activity
DescriptionDacomitinib impurity 3 is a known impurity associated with the tyrosine kinase inhibitor Dacomitinib. This compound can be utilized in analytical studies to evaluate the purity and stability of pharmaceutical formulations containing Dacomitinib. Its characterization is essential for ensuring the quality and compliance of drug products in the development process.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.